The 24-hr intracarotid infusion of plasmatreated glycyl-L-glutamine (3 ,LM) produced significant enhancement of the monomeric G, and tetrameric G4 forms of acetykcholinesterase of the cat superior cervical ganglion 48 hr after denervation, in comparison with denervated, noninfused controls. No significant effect of glycyl-L-glutamine could be demonstrated 4 or 6 days after denervation. These rindings are consistent with the conclusion, drawn from a previous in vitro study, that glycyl-L-glutamine acts at a stage prior to the aggregation of the G, form into higher polymers to maintain the acetylcholinesterase content of denervated ganglia. It is proposed that the dipeptide may regulate the transcription of the DNA for acetylcholinesterase to its corresponding mRNA.
Glycyl-L-glutamine (Gly-Gln), a few closely related compounds, and an unidentified endogenous small peptide extracted from the central nervous system have been shown to maintain the acetylcholinesterase (AcChoEase; acetylcholine acetylhydrolase, EC 3.1.1.7) and butyrylcholinesterase (acylcholine acylhydrolase, EC 3.1.1.8) contents of the preganglionically denervated superior cervical ganglion (SCG) ofthe cat when infused intraarterially (1) (2) (3) (4) . In a recent investigation of the stage in the formation of AcChoEase at which Gly-Gln acts, SCG of cats were excised 1-5 days after denervation, sectioned, and cultured for 24-48 hr; in some experiments, the residual AcChoEase was totally inactivated prior to culture by treatment with (2-mercaptoethyl)dimethylamine acid oxalate. Sections were then extracted, extracts were layered on sucrose density gradients and ultracentrifuged, and fractions were assayed for AcChoEase. In nearly all cases, 10 ,M Gly-Gln caused the greatest enhancement of the monomeric G1 peak, with progressively less enhancement of the dimeric G2 and tetrameric G4 peaks. Thus, it appeared to act at some stage prior to the assembly of the monomer into higher polymers (5) .
In the present study we have examined the effect of infusion of Gly-Gln in vivo on the molecular aggregate forms of AcChoEase in the denervated cat SCG. Earlier in vivo experiments indicated that the maximal effect on maintenance of total ganglionic AcChoEase was obtained with the infusion of 3 uM Gly-Gln (following its incubation at 5°C overnight with heat-treated plasma) during the 24to 48-hr period following denervation (6) . The same procedure was followed here, with appropriate controls. In view of the positive effects obtained in vitro with SCG excised at longer intervals after denervation, 24-hr infusion studies were also conducted at corresponding times.
METHODS
Surgical and infusion procedures were identical with those reported previously (1, 6) . Under anesthesia with ketamine (20 mg/kg, intramuscularly), 1 cm was resected from both cervical sympathetic trunks; the wound was sutured and Combiotic (penicillin/dihydrostreptomycin, 0.5 ml intramuscularly; Pfizer) was given. One to 5 days later, cats were anesthetized with sodium pentobarbital (35 mg/kg, intraperitoneally) and treated with atropine (1.0 mg/kg, intraperitoneally); artificial respiration was administered through a tracheal catheter attached to a Palmer pump, and a slow intravenous infusion of 5% glucose/0.45% NaCl was started. Heparin (50 units/kg, intravenously) was given just prior to bilateral ligation of the external carotid and lingual arteries and was repeated every 8 hr. Infusion of the solution under test [Gly-Gln, incubated overnight with heat-treated cat plasma and diluted to 3 ,uM with 0.9% NaCl (6) ] was begun and continued until the time of sacrifice, =24 hr later, with a total of =400 ml. The solution was infused by a 27-gauge hypodermic needle inserted into the right common carotid artery and attached by Tygon tubing to a reservoir enclosed in an ice-water bath. A Harvard peristaltic pump and a mercury manometer were interposed. Deep anesthesia was maintained by repeated intravenous doses of sodium pentobarbital as required; atropine or mephentermine was administered whenever wheezing respiration or persistent hypotension occurred. At the end of the infusion period, the SCG were excised, weighed, and frozen at -70°C; after a brief period in storage they were packed in dry ice and sent by Federal Express from Philadelphia to Cincinnati.
Two additional series of SCG were included: (i) denervated SCG prepared as described above and excised without infusion 2-6 days after denervation; during the 24 hr before excision, constant anesthesia with sodium pentobarbital was maintained because of its demonstrated effect of partial maintenance of residual AcChoEase (7); (ii) normal, nondenervated SCG.
Ganglia, still frozen, were received within 18 hr from the time of shipment. They were kept frozen at -70°C until homogenized in a buffer containing 1.0 M NaCl, 0.2 mM EDTA, 50 mM Tris'HCl (pH 7.4), and 1% (vol/vol) Triton X-100. The homogenates were centrifuged at 2000 x g for 1 hr, and aliquots of the supernatants were layered onto 5-20% (wt/vol) sucrose density gradients prepared in homogenization buffer. Marker proteins were also layered and the gradients were ultracentrifuged at 121,000 x gav for 15 hr in an SW 50.1 rotor in a Beckman L3-50 ultracentrifuge. The Abbreviations: AcChoEase, acetylcholinesterase; Gly-Gln, glycyl-L-glutamine; SCG, superior cervical ganglion (or ganglia). tTo whom reprint requests should be addressed.
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The AcChoEase activity was determined with a radiometric assay employing acetylcholine chloride and [acetyl-14C]acetylcholine to a final concentration of 1 mM. Fifty microliters of each gradient fraction was assayed for 0.5 hr in the presence of 45 ,uM tetraisopropyl pyrophosphoramide (iso-OMPA); the reaction was terminated with 0.1 M HCl and the cleaved acetate was extracted into a 5:1 mixture of toluene and isoamyl alcohol. After centrifugation to separate the organic and aqueous layers, radioactivity in the organic layer was measured by liquid scintillation spectroscopy. The AcChoEase activity in Fig. 1 is expressed as nmol of acetylcholine hydrolyzed per hr per mg of SCG for each fraction. The values in Table 1 were derived from the total area under the curve of each peak.
Marker proteins used to calibrate the gradients included bovine serum albumin (B4.4 S), assayed by the Bio-Rad dye-binding protein assay (peak occurred at fraction 19), and catalase (11.2 S), estimated spectrophotometrically by absorption at 404 nm (peak occurred at fraction 10). In cases where results are reported for only one SCG, the other SCG was used for studies of other factors. 
RESULTS
As observed previously (8) , preganglionic denervation of the cat SCG resulted in a greater decrease in the 10S (G4) fraction than in the 4S (G1) fraction of AcChoEase at all intervals tested ( Table 1 ). Two days after denervation, mean values in comparison with controls were 27.6% for G4 and 37.4% for G1 (cats U, C, and D). The 24-hr infusion of 3 ,uM Gly-Gln resulted in significantly higher residual values for both peaks, 49.2% for G4 and 55.3% for G1 (cats T, B, and E). These results are depicted also in Fig. la . Four days after denervation (cats Z and F), the mean G4 peak was approximately one-third, and the G1 peak one-half, that of the 2-day group, and there were no significant further changes at 6 days (cats H, M, and N; Fig. lb) . In contrast to the 2-day series, the infusion of Gly-Gln during the 24 hr preceding sacrifice had no significant effect on the value for either fraction at 4 days (cats G and 0) or 6 days (cats Y and I; Fig. lb 
DISCUSSION
The most significant present finding is the enhancement of the G1 peak, as well as of the G4 peak, of ganglionic AcChoEase produced by the infusion of 3 jLM Gly-Gln from 24 to 48 hr after denervation. This confirms the conclusion from the preceding in vitro study (5) , that Gly-Gln acts primarily at some stage in the synthesis of AcChoEase (transcription, translation, conversion of an enzymatically inactive precursor) prior to the assembly of the monomeric G1 form into higher polymers.
Investigations of the metabolism of AcChoEase in murine neuronal cell line T28 (9) and cultured chicken embryo myotubes (10) have indicated that multiple pools of the various aggregate forms exist, particularly of the G1 form, and that much of the G1 portion is degraded without being assembled into higher polymers. In the absence of further concrete evidence, it might be speculated that the G4 form is both assembled and degraded at rates higher than that of the production of the active G1 monomer; this would account for the marked decrease in the G4 peak that occurs within a few days of denervation (Fig. la) . The practically insignificant height ofthe A12 peak (representing an asymmetric, collagentailed form) in the cat SCG indicates that here most of the G4 form is also degraded without being assembled into higher polymers. The total picture in the SCG is further complicated (21.3%) Means are expressed ± SEM; values in parentheses give percentage of control mean. *Acetylcholine (nmol) hydrolyzed per mg of SCG wet weight per hr (expressed for total area under curve of peak). tOmitted from calculation of mean (>3 SEM outside mean of four remaining SCG). tGreater than 2-day denervated only, P < 0.025. by the fact that in the normal ganglion the G4 form is probably represented by two anatomically distinct pools: (i) the axoplasmic membranes of the terminals of the preganglionic fibers and (ii) the postsynaptic membranes of the ganglion cells (8, 11) . After denervation it disappears from both sites (12) . With degeneration of the preganglionic fibers, any AcChoEase of either form that is synthesized subsequently could arise only from the latter source.
The lack of any demonstrable effect of Gly-Gln at 4 and 6 days after denervation (Fig. lb) was not totally unexpected. Although enhancement ofthe G1 peak was found consistently (a) Two days after denervation. For normal control, n = 2 SCG; denervated, n = 5; denervated and infused, n = 5. (b) Six days after denervation. For normal control, n = 2; denervated, n = 3; denervated and infused, n = 3. in cultured sections excised at corresponding periods, the effect was not marked (5) . All sections employed in each in vitro experiment, control and treated, were taken from a single cat; hence, variation between sections in total Ac-ChoEase and its fractions was minimal. In the present studies we have had to compare SCG excised from Gly-Gln-infused and control cats; since the total AcChoEase content of normal cat SCG varies by more than 2-fold (1), a minor effect would probably be obscured.
In seeking a working hypothesis for the mechanism of action of Gly-Gln, an analogy can be drawn from its roughly structural and possibly functional similarity to that of triiodothyronine. The latter compound is believed to act by regulating the transcription of specific genes to mRNAs that control the synthesis of several enzymes and other proteins (13, 14) . Gly-Gln may act likewise, but in a more restricted manner, to regulate the transcription ofthe specific DNAs for AcChoEase and butyrylcholinesterase to their corresponding mRNAs. In a broader context, it is possible that other small peptides, which heretofore have been considered primarily as neurotransmitters or neuromodulators, may function similarly as neurotropic agents.
